Protection of Fecal Microbiota Transplantation in a Mouse Model of Multiple Sclerosis
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
Given the growing evidence of a link between gut microbiota (GM) dysbiosis and multiple sclerosis (MS), fecal microbiota transplantation (FMT), aimed at rebuilding GM, has been proposed as a new therapeutic approach to MS treatment. To evaluate the viability of FMT for MS treatment and its impact on MS pathology, we tested FMT in mice with experimental autoimmune encephalomyelitis (EAE), a mouse model of MS. We provide evidence that FMT can rectify altered GM to some extent with a therapeutic effect on EAE. We also found that FMT led to reduced activation of microglia and astrocytes and conferred protection on the blood-brain barrier (BBB), myelin, and axons in EAE. Taken together, our data suggest that FMT, as a GM-based therapy, has the potential to be an effective treatment for MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
Koh, A., De Vadder, F., Kovatcheva-Datchary, P., & Bäckhed, F. (2016) · Cell · doi:10.1016/j.cell.2016.05.041 · Cited by 7,070
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385
den Besten, G., van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D.-J., & Bakker, B. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r036012 · Cited by 5,048
Host microbiota constantly control maturation and function of microglia in the CNS
Erny, D., Hrabě de Angelis, A. L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4030 · Cited by 3,569
Vrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., Dallinga–Thie, G. M., Ackermans, M. T., Serlie, M. J., Oozeer, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.031 · Cited by 2,913
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
The gut microbiota influences blood-brain barrier permeability in mice
Braniste, V., Al-Asmakh, M., Kowal, C., Anuar, F., Abbaspour, A., Tóth, M., Korecka, A., Bakocevic, N., Ng, L. G., Kundu, P., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009759 · Cited by 2,530
Role of the gut microbiota in immunity and inflammatory disease
Kamada, N., Seo, S.-U., Chen, G. Y., & Núñez, G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3430 · Cited by 2,256
Moayyedi, P., Surette, M. G., Kim, P. T., Libertucci, J., Wolfe, M., Onischi, C., Armstrong, D., Marshall, J. K., Kassam, Z., Reinisch, W., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.001 · Cited by 1,499 · cited 1×
“So far, FMT has been tested in treating a variety of conditions including Clostridium difficile infection [42, 57], active ulcerative colitis [58], high-fat diet-induced steatohepatitis [59], metabolic syndrome [60], and CNS diseases such as epilepsy [21] and autism spectrum disorder [61].”
BackgroundKang, D.-W., Adams, J. B., Gregory, A. C., Borody, T., Chittick, L., Fasano, A., Khoruts, A., Geis, E., Maldonado, J., McDonough-Means, S., et al. (2017) · Microbiome · doi:10.1186/s40168-016-0225-7 · Cited by 1,391
Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis
Lee, Y. K., Menezes, J. S., Umesaki, Y., & Mazmanian, S. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000082107 · Cited by 1,323 · cited 1×
“Evidence from the EAE model of MS suggests a critical role for GM and its metabolites in the mechanisms behind neuroinflammation and demyelination [17, 18].”
BackgroundAlterations of the human gut microbiome in multiple sclerosis
Jangi, S., Gandhi, R., Cox, L. M., Li, N., von Glehn, F., Yan, R., Patel, B., Mazzola, M. A., Liu, S., Glanz, B. L., et al. (2016) · Nature Communications · doi:10.1038/ncomms12015 · Cited by 1,307 · cited 4×
“An increasing body of evidence reveals GM dysbiosis in MS [16, 25, 35, 36], and rebuilding GM has been proposed as an innovative approach to MS treatment.”
BackgroundInfluentialCommensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination
Berer, K., Mues, M., Koutrolos, M., Rasbi, Z. A., Boziki, M., Johner, C., Wekerle, H., & Krishnamoorthy, G. (2011) · Nature · doi:10.1038/nature10554 · Cited by 1,251
Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice
Sharon, G., Cruz, N. J., Kang, D.-W., Gandal, M. J., Wang, B., Kim, Y.-M., Zink, E. M., Casey, C. P., Taylor, B. C., Lane, C. J., et al. (2019) · Cell · doi:10.1016/j.cell.2019.05.004 · Cited by 1,182
Cekanaviciute, E., Yoo, B. B., Runia, T. F., Debelius, J. W., Singh, S., Nelson, C. A., Kanner, R., Bencosme, Y., Lee, Y. K., Hauser, S. L., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711235114 · Cited by 1,036
Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls
Chen, J., Chia, N., Kalari, K. R., Yao, J. Z., Novotna, M., Paz Soldan, M. M., Luckey, D. H., Marietta, E. V., Jeraldo, P. R., Chen, X., et al. (2016) · Scientific Reports · doi:10.1038/srep28484 · Cited by 933 · cited 2×
“An increasing body of evidence reveals GM dysbiosis in MS [16, 25, 35, 36], and rebuilding GM has been proposed as an innovative approach to MS treatment.”
BackgroundBerer, K., Gerdes, L. A., Cekanaviciute, E., Jia, X., Xiao, L., Xia, Z., Liu, C., Klotz, L., Stauffer, U., Baranzini, S. E., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711233114 · Cited by 933
Miyake, S., Kim, S., Suda, W., Oshima, K., Nakamura, M., Matsuoka, T., Chihara, N., Tomita, A., Sato, W., Kim, S.-W., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137429 · Cited by 809
Sun, M.-F., Zhu, Y.-L., Zhou, Z.-L., Jia, X.-B., Xu, Y.-D., Yang, Q., Cui, C., & Shen, Y.-Q. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.02.005 · Cited by 736 · cited 1×
“Microglia and astrocytes are known to contribute to the inflammatory pathology of MS [32], and some studies hint at a connection between their activation and GM composition [33, 34].”
BackgroundBedarf, J. R., Hildebrand, F., Coelho, L. P., Sunagawa, S., Bahram, M., Goeser, F., Bork, P., & Wüllner, U. (2017) · Genome Medicine · doi:10.1186/s13073-017-0428-y · Cited by 642
Regulation of prefrontal cortex myelination by the microbiota
Hoban, A. E., Stilling, R. M., Ryan, F. J., Shanahan, F., Dinan, T. G., Claesson, M. J., Clarke, G., & Cryan, J. F. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.42 · Cited by 635 · cited 1×
“These results lend support to GM’s involvement in the pathogenesis of EAE and echo previous observations of GM regulating BBB integrity [28], myelination [63], and microglia activation [29, 64].”
ResultShould we standardize the 1,700-year-old fecal microbiota transplantation?
Zhang, F., Luo, W., Shi, Y., Fan, Z., & Ji, G. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.251 · Cited by 619 · cited 1×
“FMT appears to be the most direct way to reconstruct GM [37, 38] and is in fact an ancient treatment dating back to 1700 years ago [39].”
BackgroundMicrobiome–host systems interactions: protective effects of propionate upon the blood–brain barrier
Hoyles, L., Snelling, T., Umlai, U.-K., Nicholson, J. K., Carding, S. R., Glen, R. C., & McArthur, S. (2018) · Microbiome · doi:10.1186/s40168-018-0439-y · Cited by 591
Role of Gut Commensal Microflora in the Development of Experimental Autoimmune Encephalomyelitis
Ochoa-Repáraz, J., Mielcarz, D. W., Ditrio, L. E., Burroughs, A. R., Foureau, D. M., Haque-Begum, S., & Kasper, L. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900747 · Cited by 590
Intermittent Fasting Confers Protection in CNS Autoimmunity by Altering the Gut Microbiota
Cignarella, F., Cantoni, C., Ghezzi, L., Salter, A., Dorsett, Y., Chen, L., Phillips, D., Weinstock, G. M., Fontana, L., Cross, A. H., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.05.006 · Cited by 568
Heintz‐Buschart, A., Pandey, U., Wicke, T., Sixel‐Döring, F., Janzen, A., Sittig‐Wiegand, E., Trenkwalder, C., Oertel, W. H., Mollenhauer, B., & Wilmes, P. (2018) · Movement Disorders · doi:10.1002/mds.27105 · Cited by 554 · cited 1×
“Moreover, increase of gut Akkermansia has been implicated in Parkinson’s disease [53, 54] and advanced dementia [55]; these results showed a negative role for intestinalAkkermansia in CNS disorders.”
Nylander, A., & Hafler, D. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58649 · Cited by 495
Paramsothy, S., Paramsothy, R., Rubin, D. T., Kamm, M. A., Kaakoush, N. O., Mitchell, H. M., & Castaño-Rodríguez, N. (2017) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx063 · Cited by 436 · cited 1×
“Fecal microbiota transplantation (FMT) appears to be an effective treatment for Clostridium difficile infection and inflammatory bowel syndrome, able to restore GM diversity to some extent [19, 20].”
BackgroundZhou, D., Pan, Q., Shen, F., Cao, H.-X., Ding, W.-J., Chen, Y.-W., & Fan, J.-G. (2017) · Scientific Reports · doi:10.1038/s41598-017-01751-y · Cited by 421 · cited 1×
“So far, FMT has been tested in treating a variety of conditions including Clostridium difficile infection [42, 57], active ulcerative colitis [58], high-fat diet-induced steatohepatitis [59], metabolic syndrome [60], and CNS diseases such as epilepsy [21] and autism spectrum disorder [61].”
BackgroundHorai, R., Zárate-Bladés, C. R., Dillenburg-Pilla, P., Chen, J., Kielczewski, J. L., Silver, P. B., Jittayasothorn, Y., Chan, C.-C., Yamane, H., Honda, K., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.014 · Cited by 402
Ochoa-Repáraz, J., Mielcarz, D. W., Ditrio, L. E., Burroughs, A. R., Begum-Haque, S., Dasgupta, S., Kasper, D. L., & Kasper, L. H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001443 · Cited by 367 · cited 1×
“Bacteroides fragilis PSA+ regulated CNS demyelination by the induction of highly potent IL-10-producing Treg cells in EAE [52].”
BackgroundGut microbiota in early pediatric multiple sclerosis: a case−control study
Tremlett, H., Fadrosh, D. W., Faruqi, A. A., Zhu, F., Hart, J., Roalstad, S., Graves, J., Lynch, S., Waubant, E., & the US Network of Pediatric MS Centers (2016) · European Journal of Neurology · doi:10.1111/ene.13026 · Cited by 347
Butyrate and Dietary Soluble Fiber Improve Neuroinflammation Associated With Aging in Mice
Matt, S. M., Allen, J. M., Lawson, M. A., Mailing, L. J., Woods, J. A., & Johnson, R. W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01832 · Cited by 330
Floris, S., Blezer, E. L. A., Schreibelt, G., Döpp, E., van der Pol, S. M. A., Schadee‐Eestermans, I. L., Nicolay, K., Dijkstra, C. D., & de Vries, H. E. (2004) · Brain · doi:10.1093/brain/awh068 · Cited by 272
A probiotic modulates the microbiome and immunity in multiple sclerosis
Tankou, S. K., Regev, K., Healy, B. C., Tjon, E., Laghi, L., Cox, L. M., Kivisäkk, P., Pierre, I. V., Hrishikesh, L., Gandhi, R., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25244 · Cited by 264
The Role of Astrocytes in Multiple Sclerosis Progression
Correale, J., & Farez, M. F. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00180 · Cited by 261
Gut reactions: how the blood-brain barrier connects the microbiome and the brain
Logsdon, A. F., Erickson, M. A., Rhea, E. M., Salameh, T. S., & Banks, W. A. (2018) · Experimental Biology and Medicine · doi:10.1177/1535370217743766 · Cited by 235
Fecal microbiota transplantation broadening its application beyond intestinal disorders
Xu, M.-Q. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i1.102 · Cited by 231 · cited 1×
“Some case reports suggest that FMT may help improve symptoms of epilepsy and Parkinson’s disease [21, 22].”
BackgroundThe dual role of short fatty acid chains in the pathogenesis of autoimmune disease models
Mizuno, M., Noto, D., Kaga, N., Chiba, A., & Miyake, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173032 · Cited by 230
Fecal microbiota transplantation cured epilepsy in a case with Crohn’s disease: The first report
He, Z., Cui, B.-T., Zhang, T., Li, P., Long, C.-Y., Ji, G.-Z., & Zhang, F.-M. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i19.3565 · Cited by 225
Fecal Microbiota Transplantation for Primary Clostridium difficile Infection
Juul, F. E., Garborg, K., Bretthauer, M., Skudal, H., Øines, M. N., Wiig, H., Rose, Ø., Seip, B., Lamont, J. T., Midtvedt, T., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmc1803103 · Cited by 220
Liu, S., Rezende, R. M., Moreira, T. G., Tankou, S. K., Cox, L. M., Wu, M., Song, A., Dhang, F. H., Wei, Z., Costamagna, G., et al. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.10.008 · Cited by 198
Multiple Sclerosis Relapses: Epidemiology, Outcomes and Management. A Systematic Review
Kalincik, T. (2015) · Neuroepidemiology · doi:10.1159/000382130 · Cited by 163
Li, Y.-T., Cai, H.-F., Wang, Z.-H., Xu, J., & Fang, J.-Y. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13492 · Cited by 157
Investigation of probiotics in multiple sclerosis
Tankou, S. K., Regev, K., Healy, B. C., Cox, L. M., Tjon, E., Kivisakk, P., Vanande, I. P., Cook, S., Gandhi, R., Glanz, B., et al. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458517737390 · Cited by 156 · cited 1×
“We also found that FMT treatment for EAE markedly reduced the abundance of Akkermansia genus (in phylum Verrucomicrobia) and elevated the abundance of Prevotella genus (in phylum Bacteroidetes) in GM (Figures 1(b), 1(f), and 1(g)), which recalls the findings of decreased gut Akkermansia after probiotic intervention [4…”
BackgroundFocusing on claudin-5: A promising candidate in the regulation of BBB to treat ischemic stroke
Lv, J., Hu, W., Yang, Z., Li, T., Jiang, S., Ma, Z., Chen, F., & Yang, Y. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.12.001 · Cited by 148
Bajaj, J. S., Kakiyama, G., Savidge, T., Takei, H., Kassam, Z. A., Fagan, A., Gavis, E. A., Pandak, W. M., Nittono, H., Hylemon, P. B., et al. (2018) · Hepatology · doi:10.1002/hep.30037 · Cited by 144
Fecal microbiota transplantation associated with 10 years of stability in a patient with SPMS
Makkawi, S., Camara-Lemarroy, C., & Metz, L. (2018) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000459 · Cited by 142
Transplantation of human microbiota into conventional mice durably reshapes the gut microbiota
Wrzosek, L., Ciocan, D., Borentain, P., Spatz, M., Puchois, V., Hugot, C., Ferrere, G., Mayeur, C., Perlemuter, G., & Cassard, A.-M. (2018) · Scientific Reports · doi:10.1038/s41598-018-25300-3 · Cited by 142
Microbiota and neuroimmune signalling—Metchnikoff to microglia
Cryan, J. F., & Dinan, T. G. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.127 · Cited by 134
Wang, Y., Begum-Haque, S., Telesford, K. M., Ochoa-Repáraz, J., Christy, M., Kasper, E. J., Kasper, D. L., Robson, S. C., & Kasper, L. H. (2014) · Gut Microbes · doi:10.4161/gmic.29797 · Cited by 122
Rodríguez-Morató, J., Matthan, N. R., Liu, J., de la Torre, R., & Chen, C.-Y. O. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.08.019 · Cited by 118
Therapeutic faecal microbiota transplantation: current status and future developments
Borody, T. J., Brandt, L. J., & Paramsothy, S. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000027 · Cited by 114
Commensal microbiota influence systemic autoimmune responses
Praet, J. T. V., Donovan, E., Vanassche, I., Drennan, M. B., Windels, F., Dendooven, A., Allais, L., Cuvelier, C. A., van de Loo, F. A. J., Norris, P. S., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201489966 · Cited by 110
Immune-mediated disease genetics: the shared basis of pathogenesis
Cotsapas, C., & Hafler, D. A. (2013) · Trends in Immunology · doi:10.1016/j.it.2012.09.001 · Cited by 109
Zheng, X., Hu, X., Zhou, G., Lu, Z., Qiu, W., Bao, J., & Dai, Y. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.12.001 · Cited by 107
Paramsothy, S., Paramsothy, R., Kamm, M. A., Kaakoush, N. O., Mitchell, H. M., Rubin, D. T., & Castaño‐Rodríguez, N. (2017) · Gastroenterology · doi:10.1016/s0016-5085(17)33417-0 · Cited by 87
Lee, H., Hwang, Y., & Kim, D. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800359 · Cited by 79
Sodium Butyrate Exerts Neuroprotective Effects in Spinal Cord Injury
Lanza, M., Campolo, M., Casili, G., Filippone, A., Paterniti, I., Cuzzocrea, S., & Esposito, E. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1347-7 · Cited by 79
van den Hoogen, W. J., Laman, J. D., & ’t Hart, B. A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01081 · Cited by 74
Does the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis Pathophysiology?
Adamczyk-Sowa, M., Medrek, A., Madej, P., Michlicka, W., & Dobrakowski, P. (2017) · Journal of Immunology Research · doi:10.1155/2017/7904821 · Cited by 67
Chevalier, A. C., & Rosenberger, T. A. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14032 · Cited by 50
Stanisavljević, S., Lukić, J., Momčilović, M. B., Miljković, M., Jevtić, B., Kojić, M., Golić, N., Stojković, M. M., & Miljković, D. M. (2016) · Beneficial Microbes · doi:10.3920/bm2015.0159 · Cited by 36
Stanisavljević, S., Dinić, M., Jevtić, B., Nikolovski, N., Momčilović, M. B., Đokić, J., Golić, N., Stojković, M. M., & Miljković, D. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00942 · Cited by 34
Fecal Microbiome Among Nursing Home Residents with Advanced Dementia and Clostridium difficile
Araos, R., Andreatos, N., Ugalde, J., Mitchell, S., Mylonakis, E., & D’Agata, E. M. C. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5030-7 · Cited by 29
Mullish, B. H., McDonald, J. A. K., Thursz, M. R., & Marchesi, J. R. (2018) · Hepatology · doi:10.1002/hep.30090 · Cited by 13
Cited by
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Wang, Q., Luo, Y., Ray Chaudhuri, K., Reynolds, R., Tan, E.-K., & Pettersson, S. (2021) · Brain · doi:10.1093/brain/awab156 · Cited by 281
Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies
Zhang, X., Tang, B., & Guo, J. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00392-8 · Cited by 187
“It has been proven that patients with different neurological diseases, including PD, benefit from FMT therapy [298–300].”
BackgroundCheca-Ros, A., Jeréz-Calero, A., Molina-Carballo, A., Campoy, C., & Muñoz-Hoyos, A. (2021) · Nutrients · doi:10.3390/nu13010249 · Cited by 164
“In a mouse model of multiple sclerosis, fecal microbiota transplantation rebuilt the gut microbiome and provided therapeutic benefits by conferring protection on the myelin, with additional effects on the blood–brain barrier and the populations of astrocytes [63].”
BackgroundGheorghe, C. E., Ritz, N. L., Martin, J. A., Wardill, H. R., Cryan, J. F., & Clarke, G. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1941711 · Cited by 148
Targeting the gut to treat multiple sclerosis
Ghezzi, L., Cantoni, C., Pinget, G. V., Zhou, Y., & Piccio, L. M. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143774 · Cited by 122
Metadata
- Authors
- Li, K., Wei, S., Hu, L., Yin, X., Mai, Y., Jiang, C., Peng, X., Cao, X., Huang, Z., Zhou, H., Ma, G., Liu, Z., Li, H., & Zhao, B.
- Affiliations
- Guangdong Medical College (CN)
- University College London (GB)
- Corresponding author
- Liu, Zhou
- Li, Huiliang
- Zhao, Bin
- ORCID
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2020-08-05
- Volume
- 2020
- Pages
- 1-13
- ISSN
- 0962-9351 (ISSN-L)
- 1466-1861
- PMC
- PMC7426773
- OpenAlex
- W3047080278
- Semantic Scholar
- b6c42028598fcd596386f6e4810382a0f19b46f5
- Cited by
- 92
- References
- 66
- Citations by year
- 2026: 3 · 2025: 15 · 2024: 17 · 2023: 23 · 2022: 15 · 2021: 18 · 2020: 1
- FWCI
- 9.37
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Mediators of Inflammation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Affiliated Hospital of GMU (LCYJ2018A003, BJ201612, BJ201515, M2016037, 20182074, A2020282, 2018A01021, 2019KTSCX045, 2020A1515011284, 81400986)
- GMU (LCYJ2018A003, BJ201612, BJ201515, M2016037, 20182074, A2020282, 2018A01021, 2019KTSCX045, 2020A1515011284, 81400986)
- Traditional Chinese Medicine Bureau of Guangdong Province (LCYJ2018A003, BJ201612, BJ201515, M2016037, 20182074, A2020282, 2018A01021, 2019KTSCX045, 2020A1515011284, 81400986)
- Medical Scientific Research Foundation of Guangdong Province (LCYJ2018A003, BJ201612, BJ201515, M2016037, 20182074, A2020282, 2018A01021, 2019KTSCX045, 2020A1515011284, 81400986)
- Science and Technology Planning Project of Zhanjiang (LCYJ2018A003, BJ201612, BJ201515, M2016037, 20182074, A2020282, 2018A01021, 2019KTSCX045, 2020A1515011284, 81400986)
- Ordinary Colleges and Universities in Guangdong (LCYJ2018A003, BJ201612, BJ201515, M2016037, 20182074, A2020282, 2018A01021, 2019KTSCX045, 2020A1515011284, 81400986)
- Natural Science Foundation of Guangdong Province (LCYJ2018A003, BJ201612, BJ201515, M2016037, 20182074, A2020282, 2018A01021, 2019KTSCX045, 2020A1515011284, 81400986)
- National Natural Science Foundation of China (LCYJ2018A003, BJ201612, BJ201515, M2016037, 20182074, A2020282, 2018A01021, 2019KTSCX045, 2020A1515011284, 81400986)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- fecal microbiota transplantation, multiple sclerosis, experimental autoimmune encephalomyelitis, gut dysbiosis, microglial activation, astrocyte activation, blood-brain barrier, myelin, axons, neuroprotection, microbiota-based therapy
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Animals, Axons, Blood-Brain Barrier, Disease Models, Animal, Feces, Female, Fluorescent Antibody Technique, Mice, Inbred C57BL, Multiple Sclerosis, Myelin Sheath, RNA, Ribosomal, 16S, Blotting, Western, Microscopy, Electron, Transmission, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.